These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 34276654)

  • 21. Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure.
    Ambreen A; Jamil M; Rahman MAU; Mustafa T
    BMC Infect Dis; 2019 Oct; 19(1):923. PubMed ID: 31666021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical response of newly diagnosed HIV seropositive & seronegative pulmonary tuberculosis patients with the RNTCP Short Course regimen in Pune, India.
    Tripathy S; Anand A; Inamdar V; Manoj MM; Khillare KM; Datye AS; Iyer R; Kanoj DM; Thakar M; Kale V; Pereira M; Risbud AR
    Indian J Med Res; 2011 May; 133(5):521-8. PubMed ID: 21623038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hematological Parameters in Patients with Pulmonary Tuberculosis and its Presentation among Favorable and Unfavorable Treatment Outcomes.
    Kumar SR; Kandhasamy C; Velayutham VB; Chinnaiyan P; Kannan M; Jawahar MS; Padmapriyadarsini C
    Indian J Public Health; 2024 Jul; 68(3):362-365. PubMed ID: 39321223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India.
    Sethi S; Mewara A; Dhatwalia SK; Singh H; Yadav R; Singh K; Gupta D; Wanchu A; Sharma M
    BMC Infect Dis; 2013 Mar; 13():137. PubMed ID: 23497169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors impacting early mortality in tuberculosis/HIV patients: differences between subjects naïve to and previously started on HAART.
    Schmaltz CA; Santoro-Lopes G; Lourenço MC; Morgado MG; Velasque Lde S; Rolla VC
    PLoS One; 2012; 7(9):e45704. PubMed ID: 23049842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct TB-antigen stimulated cytokine profiles as predictive biomarkers for unfavorable treatment outcomes in pulmonary tuberculosis.
    Pandiarajan AN; Kumar NP; Selvaraj N; Ahamed SF; Viswanathan V; Thiruvengadam K; Hissar S; Shanmugam S; Bethunaickan R; Nott S; Kornfeld H; Babu S
    Front Immunol; 2024; 15():1392256. PubMed ID: 38887283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical aspects and treatment outcome in HIV-associated pulmonary tuberculosis: an experience from a Thai referral centre.
    Hongthiamthong P; Riantawan P; Subhannachart P; Fuangtong P
    J Med Assoc Thai; 1994 Oct; 77(10):520-5. PubMed ID: 7745373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda.
    Nakiyingi L; Ssengooba W; Nakanjako D; Armstrong D; Holshouser M; Kirenga BJ; Shah M; Mayanja-Kizza H; Joloba ML; Ellner JJ; Dorman SE; Manabe YC
    BMC Infect Dis; 2015 Feb; 15():62. PubMed ID: 25888317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effect of Diabetes and Prediabetes on Antituberculosis Treatment Outcomes: A Multicenter Prospective Cohort Study.
    Arriaga MB; Araújo-Pereira M; Barreto-Duarte B; Nogueira B; Freire MVCNS; Queiroz ATL; Rodrigues MMS; Rocha MS; Souza AB; Spener-Gomes R; Carvalho ACC; Figueiredo MC; Turner MM; Durovni B; Lapa-E-Silva JR; Kritski AL; Cavalcante S; Rolla VC; Cordeiro-Santos M; Sterling TR; Andrade BB;
    J Infect Dis; 2022 Feb; 225(4):617-626. PubMed ID: 34651642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical forms and outcome of tuberculosis in HIV-infected patients in a tertiary hospital in São Paulo - Brazil.
    Klautau GB; Kuschnaroff TM
    Braz J Infect Dis; 2005 Dec; 9(6):464-78. PubMed ID: 16410941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome correlation of smear-positivity for acid-fast bacilli at the fifth month of treatment in non-multidrug-resistant TB.
    Chien JY; Chen YT; Shu CC; Lee JJ; Wang JY; Yu CJ; Yang PC
    Chest; 2013 Jun; 143(6):1725-1732. PubMed ID: 23288018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retreatment tuberculosis cases. Factors associated with drug resistance and adverse outcomes.
    Kritski AL; Rodrigues de Jesus LS; Andrade MK; Werneck-Barroso E; Vieira MA; Haffner A; Riley LW
    Chest; 1997 May; 111(5):1162-7. PubMed ID: 9149564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens.
    Yew WW; Chan CK; Chau CH; Tam CM; Leung CC; Wong PC; Lee J
    Chest; 2000 Mar; 117(3):744-51. PubMed ID: 10713001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence, Predictors, and Successful Treatment Outcomes of Xpert MTB/RIF-identified Rifampicin-resistant Tuberculosis in Post-conflict Eastern Democratic Republic of the Congo, 2012-2017: A Retrospective Province-Wide Cohort Study.
    Bulabula ANH; Nelson JA; Musafiri EM; Machekano R; Sam-Agudu NA; Diacon AH; Shah M; Creswell J; Theron G; Warren RM; Jacobson KR; Chirambiza JP; Kalumuna D; Bisimwa BC; Katoto PDMC; Kaswa MK; Birembano FM; Kitete L; Grobusch MP; Kashongwe ZM; Nachega JB
    Clin Infect Dis; 2019 Sep; 69(8):1278-1287. PubMed ID: 30759187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depressed Gamma Interferon Responses and Treatment Outcomes in Tuberculosis Patients: a Prospective Cohort Study.
    Feng JY; Pan SW; Huang SF; Chen YY; Lin YY; Su WJ
    J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30068533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for unsuccessful tuberculosis treatment outcome (failure, default and death) in public health institutions, Eastern Ethiopia.
    Amante TD; Ahemed TA
    Pan Afr Med J; 2015; 20():247. PubMed ID: 26161170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characteristics and treatment outcomes among patients with tuberculosis in Bangkok and Nonthaburi, Thailand.
    Manosuthi W; Kawkitinarong K; Suwanpimolkul G; Chokbumrungsuk C; Jirawattanapisal T; Ruxrungtham K; Akksilp S
    Southeast Asian J Trop Med Public Health; 2012 Nov; 43(6):1426-36. PubMed ID: 23413706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical predictors and accuracy of empiric tuberculosis treatment among sputum smear-negative HIV-infected adult TB suspects in Uganda.
    Nakiyingi L; Bwanika JM; Kirenga B; Nakanjako D; Katabira C; Lubega G; Sempa J; Nyesiga B; Albert H; Manabe YC
    PLoS One; 2013; 8(9):e74023. PubMed ID: 24040151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment.
    Friedrich SO; Rachow A; Saathoff E; Singh K; Mangu CD; Dawson R; Phillips PP; Venter A; Bateson A; Boehme CC; Heinrich N; Hunt RD; Boeree MJ; Zumla A; McHugh TD; Gillespie SH; Diacon AH; Hoelscher M;
    Lancet Respir Med; 2013 Aug; 1(6):462-70. PubMed ID: 24429244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isoniazid Monoresistance and Rate of Culture Conversion among Patients in the State of Georgia with Confirmed Tuberculosis, 2009-2014.
    Salindri AD; Sales RF; DiMiceli L; Schechter MC; Kempker RR; Magee MJ
    Ann Am Thorac Soc; 2018 Mar; 15(3):331-340. PubMed ID: 29131662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.